.png){kind=small}
.png){kind=small}
.png)
HCC Creator Weekend™
Listen to the Hepatocellular Carcinoma (HCC) Creator Weekend™ on BackTable. This 9-part, in-studio podcast series features 15 interdisciplinary experts, including medical oncologists, interventional oncologsits, hepatobiliary surgeons, hepatologyists radiation oncologists, and oncologic nurses. Physicians, nurses, nurse practitioners, and physician assistants can claim free CME / CE for completing learning activities related to these episodes.
Featured Podcast
Tumor Board Episode #3
Combination Therapy and Clinical Trials for Advanced HCC: What They Really Mean
with Dr. Lingling Du, Dr. Jonathan Mizrahi, Dr. Adam Burgoyne and Dr. Zach Berman
In the past five years, the use of immunotherapeutic agents for advanced cancers has emerged as a promising alternative to tyrosine kinase inhibitors and chemotherapy, making it an exciting time to be practicing oncology. In this episode, Dr. Tyler Sandow interviews oncology experts about the landscape of advanced hepatocellular carcinoma (HCC) and the current state of immunotherapy treatments. He is joined by medical oncologists Dr. Jonathan Mizrah, Dr. Lingling Du, and Dr. Adam Burgoyne, as well as interventional oncologist Dr. Zachary Berman.
This podcast is supported by an educational grant from AstraZeneca Pharmaceuticals and Boston Scientific.
